The content of this website is intended for healthcare professionals only

Medicinal cannabis will be legal from next month

Specialist doctors and not GPs will be able to prescribe cannabis

Adrian O'Dowd

Friday, 12 October 2018

Only specialist doctors and not GPs will be able to prescribe medicinal cannabis from 1 November, the government has announced.

A change in the law, laid in parliament yesterday, means that for the first time in the UK, expert doctors will be given the option to legally issue prescriptions for cannabis-based medicines when they agree that their patients could benefit from this treatment.

The Home Office said the law change had come after home secretary Sajid Javid listened to concerns from parents of children with conditions such as severe epilepsy.

Over the summer, Mr Javid called for an urgent review of cannabis-based medicinal products and accepted recommendations that followed from the Advisory Council on the Misuse of Drugs (ACMD) and the UK’s chief medical adviser.

The new law will not limit the types of conditions that can be considered for treatment and doctors will no longer need to seek approval from an expert panel in order for patients to access the medicines.

The Home Office has stressed that the penalties for unauthorised supply and possession of cannabis for recreational use remain unchanged.

A decision to prescribe these unlicensed medicines must be made by a specialist doctor and not a GP, said the Home Office. These specialist doctors focus on one field of medicine such as neurology or paediatrics and are listed on the GMC’s specialist register.

They will have to make decisions on prescribing cannabis-based products for medicinal use on a case-by-case basis, and only when the patient has an unmet special clinical need that cannot be met by licensed products.

NHS England, the British Paediatric Neurology Association and the Royal College of Physicians will provide clinical advice to doctors ahead of the law change.

NICE has also been commissioned to develop more detailed guidelines for clinicians in the longer-term.

Mr Javid said: “Having been moved by heartbreaking cases involving sick children, it was important to me that we took swift action to help those who can benefit from medicinal cannabis. We have now delivered on our promise and specialist doctors will have the option to prescribe these products where there is a real need.

“I’m grateful to the expert panel – who have been considering cases in the interim – and to those who’ve worked hard to bring about this change at the earliest possible opportunity.”

President of the Royal Pharmaceutical Society, Professor Ashok Soni, said: “This news will be welcomed by many patients with serious health conditions. The prospect of a future where safe and effective licensed cannabis-based medicines can be prescribed to help relieve suffering is genuinely exciting.

“We will work with the NHS to help support specialists in making the right prescribing decisions.”

Registered in England and Wales. Reg No. 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Reg No. 30158470
Twitter Facebook
A Wilmington Company